UPDATE: Bank Of America Reiterates On Regeneron Pharmaceuticals Following Several Positive Catalysts

By: via Benzinga
In a report published Friday, Bank of America analyst Ying Huang reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ: REGN), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.